These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 9107118)

  • 21. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone density in long term users of depot medroxyprogesterone acetate.
    Gbolade B; Ellis S; Murby B; Randall S; Kirkman R
    Br J Obstet Gynaecol; 1998 Jul; 105(7):790-4. PubMed ID: 9692421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DMPA use above the age of 35 in Thai women.
    Taneepanichskul S; Reinprayoon D; Phaosavadi S
    Contraception; 2000 Apr; 61(4):281-2. PubMed ID: 10899485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
    Hu E; Ikeako LC; Obiora-Okafor NC
    Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis.
    Pardthaisong T
    J Biosoc Sci; 1984 Jan; 16(1):23-34. PubMed ID: 6230362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
    Fraser IS
    Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
    Fraser IS
    Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Contraception with injectable long-acting preparation depo-provera].
    Prilepskaia VN; Kondrikov NI; Tagieva TT
    Akush Ginekol (Mosk); 1995; (3):7-10. PubMed ID: 7653732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depressive symptoms in users and non-users of depot medroxyprogesterone acetate.
    Civic D; Scholes D; Ichikawa L; LaCroix AZ; Yoshida CK; Ott SM; Barlow WE
    Contraception; 2000 Jun; 61(6):385-90. PubMed ID: 10958882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depo Provera: still controversial.
    Wren LM
    Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depo Provera: a profile of current users.
    Jarman H; Kovacs GT; Westcott M
    Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism.
    Garza-Flores J; De la Cruz DL; Valles de Bourges V; Sanchez-Nuncio R; Martinez M; Fuziwara JL; Pérez-Palacios G
    Contraception; 1991 Jul; 44(1):61-71. PubMed ID: 1832626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depressive symptoms and Depo-Provera.
    Westhoff C; Truman C; Kalmuss D; Cushman L; Davidson A; Rulin M; Heartwell S
    Contraception; 1998 Apr; 57(4):237-40. PubMed ID: 9649914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injectable contraception: the USA perspective.
    Kaunitz AM
    IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contraception update: implantable and injectable methods.
    Gold MA
    Pediatr Ann; 1995 Apr; 24(4):203-7. PubMed ID: 7596649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS
    J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subdermal contraceptive implants in nurse-midwifery practice.
    Emerling JM; Paluzzi P; Leiva J; Cullins VE
    J Nurse Midwifery; 1993; 38(2 Suppl):80S-87S. PubMed ID: 8483013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation.
    Paul C; Skegg DC; Williams S
    Contraception; 1997 Oct; 56(4):209-14. PubMed ID: 9408701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.
    Vercellini P; De Giorgi O; Oldani S; Cortesi I; Panazza S; Crosignani PG
    Am J Obstet Gynecol; 1996 Aug; 175(2):396-401. PubMed ID: 8765259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.